Caris Life Sciences, Inc. (CAI)
19.29
+0.16
(+0.84%)
USD |
NASDAQ |
Apr 02, 16:00
19.28
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences EPS Diluted (Quarterly) : 0.2901 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 1.482 |
| Glaukos Corp. | -2.324 |
| Edgewise Therapeutics, Inc. | -0.4737 |
| Nuvalent, Inc. | -1.585 |
| Alphatec Holdings, Inc. | -0.1428 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 81.96M |
| Revenue (Quarterly) | 292.89M |
| Total Expenses (Quarterly) | 210.93M |
| Enterprise Value | 5.070B |
| Gross Profit Margin (Quarterly) | 75.43% |
| Profit Margin (Quarterly) | 27.98% |
| Earnings Yield | -9.85% |
| Operating Earnings Yield | 0.82% |
| Normalized Earnings Yield | -8.927 |